We’re about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are … – Business Insider
Health Thoroughfare |
We're about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are …
Business Insider On Monday, three big players in the growing field of cancer immunotherapy are sharing data that could change how we treat lung cancer. The three companies, Bristol-Myers Squibb, Merck, and Roche, are looking at how their immunotherapies, known as … Immunotherapy, a Wonder for the Lung Cancer Patients EGFR+ NSCLC: Treatment Through Multiple Lines of Therapy |
